Previous 10 | Next 10 |
2024-04-13 12:38:54 ET Summary QuidelOrtho's profitability has been impacted by higher depreciation and non-operating expenses, but improvements in gross margins and reduced expenses are expected in 2024. The company's revenue growth in 2023 was below targets, with the Labs segmen...
Helping hospital and emergency room customers respond to the critical demand for enhanced opioid testing QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600...
2024-04-02 15:15:02 ET William Blair analyst issues MARKET PERFORM recommendation for QDEL on April 2, 2024 02:16PM ET. The previous analyst recommendation was Market Perform. QDEL was trading at $42.2 at issue of the analyst recommendation. The overall analyst consensus...
2024-04-02 14:01:12 ET More on Mineralys Therapeutics, Quidel, etc. Mineralys Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation Mineralys Therapeutics, Inc. (MLYS) Q4 2023 Earnings Call Transcript Mineralys Therapeutics: A Story To Keep An Eye On ...
2024-04-02 09:17:49 ET More on Quidel QuidelOrtho: Uncertainty Reigns QuidelOrtho Corporation 2023 Q4 - Results - Earnings Call Presentation QuidelOrtho Corporation (QDEL) Q4 2023 Earnings Call Transcript UBS cuts QuidelOrtho to sell, cites potential downside...
Test Delivers on Company Commitment to Advance the Power of Diagnostics to Empower Patients with Rapid Results in Just 10 Minutes Savanna® RVP4+ Assay Research and Development Update QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho" or the “Company”...
2024-03-28 13:49:05 ET More on Invesco S&P 500 Equal Weight ETF: RSP: Equal Weighting The S&P 500 To Minimize Magnificent Seven Exposure Is Not Optimal RSP: I Firmly Believe In An Allocation To Equal-Weight At This Juncture RSP: Happy 2024! Don't Make Decisio...
2024-03-20 03:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-15 15:16:36 ET More on the markets Fairlead Strategies founder: This year is the year of the long-term turnarounds Inflation Is Not Running Hot S&P 500: Stay Invested, Cut Risk, And Be Ready To Buy The Dips The next Nvidia? Goldman Sachs spotlight...
2024-03-09 23:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 05:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.7% to $118.11 on volume of 457,565,587 shares Agrify Corporation (AGFY) rose 68.7% to $0.4251 on volume of 291,898,257 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 13.7% to $0.3662 on volume...
2024-06-19 06:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...